Life Sciences & Biomedicine Medicine, Research & Experimental Research & Experimental Medicine Science & Technology
Osteogenesis imperfecta (OI) is a rare genetic disorder also known as a "brittle bone disease." Around 90% of patients with OI harbor loss-of-function or dominant negative pathogenic variants in the COL1A1 and COL1A2 genes, which code for collagen type I alpha 1 and alpha 2 chains. Collagen-related forms of the disorder are classified as Sillence OI types I-IV. OI phenotype expression ranges from mild to lethal. The current study aims to evaluate associations between interfamilial and intrafamilial phenotypic variability and genotype characteristics of patients with collagen-related OI. The study was based on a systematic review of collagen-related OI cases from the University of Tartu OI database (n = 137 individuals from 81 families) and the Dalgleish database (n = 479 individuals). Interfamilial variability analysis has shown that 17.74% of all studied OI-related variants were associated with the same phenotype. The remaining 82.26% of pathogenic variants were associated with variable phenotypes. Additionally, higher interfamilial variability correlated with the COL1A1 gene (P value = 0.001) and dominant-negative variants (P value = 0.0007). Within intrafamilial variability, 32.81% families had increasing or decreasing OI phenotype severity across generations. Higher intrafamilial variability of phenotypes correlated with the collagen I dominant negative variants (P value = 0.0246). The current study shows that, in line with other phenotype modification factors, OI interfamilial and intrafamilial diversity potential is associated with the genotype characteristics of the OI-causing pathogenic variants. The results of the current study may advance knowledge of OI phenotype modification as well as assist family planning and the evaluation of disease progression in subsequent generations.
Details
Title
Inter- and Intrafamilial Phenotypic Variability in Individuals with Collagen-Related Osteogenesis Imperfecta
Authors/Creators
Lidiia Zhytnik - University of Tartu
Katre Maasalu - Tartu University Hospital
Tiia Reimand - University of Tartu
Binh Ho Duy - Hue University
Sulev Koks - Perron Institute for Neurological and Translational Science
Aare Martson - University of Tartu
Publication Details
Clinical and translational science, Vol.13(5), pp.960-971
Publisher
Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Number of pages
12
Grant note
IUT20-46 / Estonian Ministry of Education and Research; Ministry of Education and Research, Estonia
Estonian Ministry of Education and Research; Ministry of Education and Research, Estonia
668989 / H2020 ERA-chair grant